Detail Information of Epigenetic Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0205 Transporter Info | ||||
Gene Name | SLC25A42 | ||||
Transporter Name | Mitochondrial coenzyme A transporter SLC25A42 | ||||
Gene ID | |||||
UniProt ID | |||||
Epigenetic Regulations of This DT (EGR) | |||||
---|---|---|---|---|---|
Methylation |
|||||
Atypical teratoid rhabdoid tumor |
10 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC25A42 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg00813603) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.27E+00 | Statistic Test | p-value:6.62E-09; Z-score:1.33E+00 | ||
Methylation in Case |
7.48E-01 (Median) | Methylation in Control | 5.90E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC25A42 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg01318291) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.17E+00 | Statistic Test | p-value:9.40E-09; Z-score:-1.47E+00 | ||
Methylation in Case |
7.08E-01 (Median) | Methylation in Control | 8.28E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC25A42 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg19547236) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.10E+00 | Statistic Test | p-value:3.32E-06; Z-score:-1.19E+00 | ||
Methylation in Case |
7.08E-01 (Median) | Methylation in Control | 7.81E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC25A42 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg23956760) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.17E+00 | Statistic Test | p-value:7.49E-06; Z-score:1.42E+00 | ||
Methylation in Case |
8.73E-01 (Median) | Methylation in Control | 7.46E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC25A42 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg02595575) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.03E+00 | Statistic Test | p-value:1.80E-04; Z-score:-8.45E-01 | ||
Methylation in Case |
8.84E-01 (Median) | Methylation in Control | 9.07E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC25A42 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg04460816) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.03E+00 | Statistic Test | p-value:7.83E-04; Z-score:-4.54E-01 | ||
Methylation in Case |
8.66E-01 (Median) | Methylation in Control | 8.90E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC25A42 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg04661001) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.09E+00 | Statistic Test | p-value:8.96E-04; Z-score:-3.75E-01 | ||
Methylation in Case |
4.19E-01 (Median) | Methylation in Control | 4.55E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC25A42 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg10665321) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.03E+00 | Statistic Test | p-value:1.72E-02; Z-score:1.05E-01 | ||
Methylation in Case |
1.21E-01 (Median) | Methylation in Control | 1.18E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC25A42 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg11287443) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.01E+00 | Statistic Test | p-value:2.10E-02; Z-score:3.45E-01 | ||
Methylation in Case |
9.35E-01 (Median) | Methylation in Control | 9.26E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon10 |
Methylation of SLC25A42 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
3'UTR (cg02677865) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.47E+00 | Statistic Test | p-value:4.02E-15; Z-score:2.40E+00 | ||
Methylation in Case |
6.97E-01 (Median) | Methylation in Control | 4.75E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Bladder cancer |
7 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC25A42 in bladder cancer | [ 2 ] | |||
Location |
5'UTR (cg23956760) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.10E+00 | Statistic Test | p-value:5.67E-03; Z-score:4.50E+00 | ||
Methylation in Case |
7.62E-01 (Median) | Methylation in Control | 6.91E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC25A42 in bladder cancer | [ 2 ] | |||
Location |
TSS200 (cg23474268) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.22E+00 | Statistic Test | p-value:2.86E-04; Z-score:-3.32E+00 | ||
Methylation in Case |
1.03E-01 (Median) | Methylation in Control | 1.26E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC25A42 in bladder cancer | [ 2 ] | |||
Location |
TSS200 (cg13423282) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.88E+00 | Statistic Test | p-value:2.74E-02; Z-score:-1.48E+00 | ||
Methylation in Case |
9.65E-02 (Median) | Methylation in Control | 1.82E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC25A42 in bladder cancer | [ 2 ] | |||
Location |
Body (cg04661001) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.41E+00 | Statistic Test | p-value:9.95E-09; Z-score:7.07E+00 | ||
Methylation in Case |
8.06E-01 (Median) | Methylation in Control | 5.73E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC25A42 in bladder cancer | [ 2 ] | |||
Location |
Body (cg25612391) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.36E+00 | Statistic Test | p-value:8.68E-07; Z-score:7.61E+00 | ||
Methylation in Case |
7.37E-01 (Median) | Methylation in Control | 5.42E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC25A42 in bladder cancer | [ 2 ] | |||
Location |
Body (cg11287443) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.24E+00 | Statistic Test | p-value:3.01E-05; Z-score:-4.86E+00 | ||
Methylation in Case |
6.71E-01 (Median) | Methylation in Control | 8.33E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC25A42 in bladder cancer | [ 2 ] | |||
Location |
Body (cg02595575) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:4.63E-03; Z-score:-3.19E-02 | ||
Methylation in Case |
4.56E-02 (Median) | Methylation in Control | 4.62E-02 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Breast cancer |
13 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC25A42 in breast cancer | [ 3 ] | |||
Location |
5'UTR (cg23956760) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.07E+00 | Statistic Test | p-value:3.75E-05; Z-score:4.62E-01 | ||
Methylation in Case |
6.74E-01 (Median) | Methylation in Control | 6.33E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC25A42 in breast cancer | [ 3 ] | |||
Location |
5'UTR (cg00813603) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.28E+00 | Statistic Test | p-value:2.00E-02; Z-score:6.30E-01 | ||
Methylation in Case |
3.76E-02 (Median) | Methylation in Control | 2.95E-02 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC25A42 in breast cancer | [ 3 ] | |||
Location |
TSS1500 (cg22145172) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.21E+00 | Statistic Test | p-value:1.18E-03; Z-score:5.20E-01 | ||
Methylation in Case |
5.08E-02 (Median) | Methylation in Control | 4.21E-02 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC25A42 in breast cancer | [ 3 ] | |||
Location |
TSS200 (cg23474268) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.17E+00 | Statistic Test | p-value:4.28E-03; Z-score:-4.64E-01 | ||
Methylation in Case |
8.16E-02 (Median) | Methylation in Control | 9.56E-02 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC25A42 in breast cancer | [ 3 ] | |||
Location |
TSS200 (cg08332492) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.40E+00 | Statistic Test | p-value:1.45E-02; Z-score:4.98E-01 | ||
Methylation in Case |
1.45E-02 (Median) | Methylation in Control | 1.03E-02 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC25A42 in breast cancer | [ 3 ] | |||
Location |
TSS200 (cg13423282) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.26E+00 | Statistic Test | p-value:1.87E-02; Z-score:-3.12E-01 | ||
Methylation in Case |
3.91E-02 (Median) | Methylation in Control | 4.92E-02 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC25A42 in breast cancer | [ 3 ] | |||
Location |
Body (cg02595575) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:2.15E+00 | Statistic Test | p-value:3.97E-11; Z-score:1.99E+00 | ||
Methylation in Case |
2.65E-01 (Median) | Methylation in Control | 1.23E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC25A42 in breast cancer | [ 3 ] | |||
Location |
Body (cg20141652) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.21E+00 | Statistic Test | p-value:1.27E-09; Z-score:1.42E+00 | ||
Methylation in Case |
4.79E-01 (Median) | Methylation in Control | 3.95E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC25A42 in breast cancer | [ 3 ] | |||
Location |
Body (cg04661001) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.22E+00 | Statistic Test | p-value:4.50E-08; Z-score:2.57E+00 | ||
Methylation in Case |
7.35E-01 (Median) | Methylation in Control | 6.00E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon10 |
Methylation of SLC25A42 in breast cancer | [ 3 ] | |||
Location |
Body (cg10665321) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.20E+00 | Statistic Test | p-value:2.26E-07; Z-score:1.17E+00 | ||
Methylation in Case |
5.57E-01 (Median) | Methylation in Control | 4.65E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon11 |
Methylation of SLC25A42 in breast cancer | [ 3 ] | |||
Location |
Body (cg25612391) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.21E+00 | Statistic Test | p-value:8.40E-07; Z-score:2.01E+00 | ||
Methylation in Case |
6.04E-01 (Median) | Methylation in Control | 5.00E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon12 |
Methylation of SLC25A42 in breast cancer | [ 3 ] | |||
Location |
Body (cg04460816) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.16E+00 | Statistic Test | p-value:1.13E-06; Z-score:1.15E+00 | ||
Methylation in Case |
5.34E-01 (Median) | Methylation in Control | 4.60E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon13 |
Methylation of SLC25A42 in breast cancer | [ 3 ] | |||
Location |
Body (cg11287443) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.08E+00 | Statistic Test | p-value:5.31E-06; Z-score:1.26E+00 | ||
Methylation in Case |
8.29E-01 (Median) | Methylation in Control | 7.71E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Renal cell carcinoma |
10 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC25A42 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
5'UTR (cg00813603) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.49E+00 | Statistic Test | p-value:4.34E-05; Z-score:1.46E+00 | ||
Methylation in Case |
1.21E-02 (Median) | Methylation in Control | 8.15E-03 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC25A42 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
5'UTR (cg01318291) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.07E+00 | Statistic Test | p-value:2.28E-02; Z-score:2.88E-01 | ||
Methylation in Case |
2.15E-02 (Median) | Methylation in Control | 2.02E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC25A42 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
TSS1500 (cg22145172) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.42E+00 | Statistic Test | p-value:1.71E-04; Z-score:1.12E+00 | ||
Methylation in Case |
2.93E-02 (Median) | Methylation in Control | 2.06E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC25A42 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
TSS200 (cg23474268) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.46E+00 | Statistic Test | p-value:7.94E-13; Z-score:1.68E+00 | ||
Methylation in Case |
4.52E-02 (Median) | Methylation in Control | 3.09E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC25A42 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
TSS200 (cg13423282) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.27E+00 | Statistic Test | p-value:4.19E-05; Z-score:1.03E+00 | ||
Methylation in Case |
2.22E-02 (Median) | Methylation in Control | 1.75E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC25A42 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
TSS200 (cg08332492) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.15E+00 | Statistic Test | p-value:1.47E-04; Z-score:-8.96E-01 | ||
Methylation in Case |
1.62E-02 (Median) | Methylation in Control | 1.86E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC25A42 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
TSS200 (cg18420266) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.13E+00 | Statistic Test | p-value:2.30E-03; Z-score:-6.13E-01 | ||
Methylation in Case |
5.39E-02 (Median) | Methylation in Control | 6.09E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC25A42 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
TSS200 (cg22516671) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.20E+00 | Statistic Test | p-value:2.45E-02; Z-score:-8.32E-01 | ||
Methylation in Case |
1.26E-02 (Median) | Methylation in Control | 1.51E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC25A42 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
Body (cg04460816) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.06E+00 | Statistic Test | p-value:1.79E-02; Z-score:-5.25E-01 | ||
Methylation in Case |
4.34E-01 (Median) | Methylation in Control | 4.62E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon10 |
Methylation of SLC25A42 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
3'UTR (cg02677865) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:2.56E-04; Z-score:-1.40E+00 | ||
Methylation in Case |
9.37E-01 (Median) | Methylation in Control | 9.53E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Colon cancer |
10 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC25A42 in colon adenocarcinoma | [ 5 ] | |||
Location |
5'UTR (cg03307465) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:2.71E+00 | Statistic Test | p-value:5.84E-09; Z-score:2.63E+00 | ||
Methylation in Case |
5.56E-01 (Median) | Methylation in Control | 2.05E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC25A42 in colon adenocarcinoma | [ 5 ] | |||
Location |
TSS1500 (cg07973479) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.25E+00 | Statistic Test | p-value:4.84E-05; Z-score:-1.86E+00 | ||
Methylation in Case |
5.39E-01 (Median) | Methylation in Control | 6.72E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC25A42 in colon adenocarcinoma | [ 5 ] | |||
Location |
TSS1500 (cg16298016) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.17E+00 | Statistic Test | p-value:3.97E-04; Z-score:-2.94E+00 | ||
Methylation in Case |
6.85E-01 (Median) | Methylation in Control | 8.00E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC25A42 in colon adenocarcinoma | [ 5 ] | |||
Location |
TSS1500 (cg02319142) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.10E+00 | Statistic Test | p-value:3.51E-03; Z-score:-6.92E-01 | ||
Methylation in Case |
9.61E-02 (Median) | Methylation in Control | 1.06E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC25A42 in colon adenocarcinoma | [ 5 ] | |||
Location |
TSS200 (cg07581732) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.52E+00 | Statistic Test | p-value:2.55E-03; Z-score:1.93E+00 | ||
Methylation in Case |
3.52E-01 (Median) | Methylation in Control | 2.31E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC25A42 in colon adenocarcinoma | [ 5 ] | |||
Location |
Body (cg17044311) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.11E+00 | Statistic Test | p-value:1.89E-05; Z-score:-3.66E+00 | ||
Methylation in Case |
7.61E-01 (Median) | Methylation in Control | 8.46E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC25A42 in colon adenocarcinoma | [ 5 ] | |||
Location |
Body (cg01551177) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.19E+00 | Statistic Test | p-value:1.93E-05; Z-score:-3.99E+00 | ||
Methylation in Case |
6.38E-01 (Median) | Methylation in Control | 7.57E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC25A42 in colon adenocarcinoma | [ 5 ] | |||
Location |
Body (cg21307155) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.17E+00 | Statistic Test | p-value:4.19E-05; Z-score:-1.29E+00 | ||
Methylation in Case |
3.96E-01 (Median) | Methylation in Control | 4.64E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC25A42 in colon adenocarcinoma | [ 5 ] | |||
Location |
Body (cg04337188) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.15E+00 | Statistic Test | p-value:6.68E-05; Z-score:-3.06E+00 | ||
Methylation in Case |
6.72E-01 (Median) | Methylation in Control | 7.71E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon10 |
Methylation of SLC25A42 in colon adenocarcinoma | [ 5 ] | |||
Location |
Body (cg09945896) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.08E+00 | Statistic Test | p-value:3.39E-03; Z-score:-2.03E+00 | ||
Methylation in Case |
7.68E-01 (Median) | Methylation in Control | 8.31E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Colorectal cancer |
12 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC25A42 in colorectal cancer | [ 6 ] | |||
Location |
5'UTR (cg23956760) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.05E+00 | Statistic Test | p-value:1.20E-06; Z-score:-1.24E+00 | ||
Methylation in Case |
8.20E-01 (Median) | Methylation in Control | 8.63E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC25A42 in colorectal cancer | [ 6 ] | |||
Location |
5'UTR (cg00813603) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.10E+00 | Statistic Test | p-value:1.10E-03; Z-score:5.26E-01 | ||
Methylation in Case |
7.08E-02 (Median) | Methylation in Control | 6.42E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC25A42 in colorectal cancer | [ 6 ] | |||
Location |
5'UTR (cg01318291) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.09E+00 | Statistic Test | p-value:3.96E-02; Z-score:6.99E-01 | ||
Methylation in Case |
9.44E-02 (Median) | Methylation in Control | 8.64E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC25A42 in colorectal cancer | [ 6 ] | |||
Location |
TSS200 (cg23474268) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.14E+00 | Statistic Test | p-value:8.40E-03; Z-score:8.45E-01 | ||
Methylation in Case |
1.25E-01 (Median) | Methylation in Control | 1.10E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC25A42 in colorectal cancer | [ 6 ] | |||
Location |
TSS200 (cg08332492) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.19E+00 | Statistic Test | p-value:3.91E-02; Z-score:-5.83E-01 | ||
Methylation in Case |
1.48E-02 (Median) | Methylation in Control | 1.75E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC25A42 in colorectal cancer | [ 6 ] | |||
Location |
Body (cg04661001) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.27E+00 | Statistic Test | p-value:8.67E-10; Z-score:2.25E+00 | ||
Methylation in Case |
7.42E-01 (Median) | Methylation in Control | 5.84E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC25A42 in colorectal cancer | [ 6 ] | |||
Location |
Body (cg10665321) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.32E+00 | Statistic Test | p-value:5.60E-05; Z-score:7.71E-01 | ||
Methylation in Case |
1.19E-01 (Median) | Methylation in Control | 9.01E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC25A42 in colorectal cancer | [ 6 ] | |||
Location |
Body (cg11287443) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.03E+00 | Statistic Test | p-value:1.59E-04; Z-score:-1.06E+00 | ||
Methylation in Case |
8.63E-01 (Median) | Methylation in Control | 8.93E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC25A42 in colorectal cancer | [ 6 ] | |||
Location |
Body (cg02595575) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.16E+00 | Statistic Test | p-value:3.99E-03; Z-score:4.38E-01 | ||
Methylation in Case |
3.10E-02 (Median) | Methylation in Control | 2.67E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon10 |
Methylation of SLC25A42 in colorectal cancer | [ 6 ] | |||
Location |
Body (cg25612391) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.17E+00 | Statistic Test | p-value:8.67E-03; Z-score:1.07E+00 | ||
Methylation in Case |
4.70E-01 (Median) | Methylation in Control | 4.00E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon11 |
Methylation of SLC25A42 in colorectal cancer | [ 6 ] | |||
Location |
3'UTR (cg02677865) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:2.15E-02; Z-score:-4.42E-01 | ||
Methylation in Case |
9.23E-01 (Median) | Methylation in Control | 9.29E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Hepatocellular carcinoma |
7 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC25A42 in hepatocellular carcinoma | [ 7 ] | |||
Location |
5'UTR (cg23956760) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.10E+00 | Statistic Test | p-value:1.09E-02; Z-score:5.11E-01 | ||
Methylation in Case |
7.23E-01 (Median) | Methylation in Control | 6.55E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC25A42 in hepatocellular carcinoma | [ 7 ] | |||
Location |
TSS1500 (cg18426142) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.75E+00 | Statistic Test | p-value:3.49E-20; Z-score:-2.23E+00 | ||
Methylation in Case |
1.92E-01 (Median) | Methylation in Control | 3.38E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC25A42 in hepatocellular carcinoma | [ 7 ] | |||
Location |
TSS1500 (cg07164211) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.30E+00 | Statistic Test | p-value:2.74E-14; Z-score:-8.65E+00 | ||
Methylation in Case |
6.84E-01 (Median) | Methylation in Control | 8.91E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC25A42 in hepatocellular carcinoma | [ 7 ] | |||
Location |
TSS1500 (cg22145172) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.44E+00 | Statistic Test | p-value:1.08E-06; Z-score:-1.15E+00 | ||
Methylation in Case |
5.01E-02 (Median) | Methylation in Control | 7.23E-02 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC25A42 in hepatocellular carcinoma | [ 7 ] | |||
Location |
Body (cg26111881) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.56E+00 | Statistic Test | p-value:5.12E-18; Z-score:-4.07E+00 | ||
Methylation in Case |
4.03E-01 (Median) | Methylation in Control | 6.29E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC25A42 in hepatocellular carcinoma | [ 7 ] | |||
Location |
Body (cg24358785) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.15E+00 | Statistic Test | p-value:2.79E-12; Z-score:1.60E+00 | ||
Methylation in Case |
7.33E-01 (Median) | Methylation in Control | 6.39E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC25A42 in hepatocellular carcinoma | [ 7 ] | |||
Location |
Body (cg19478343) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.27E+00 | Statistic Test | p-value:4.97E-12; Z-score:-1.41E+01 | ||
Methylation in Case |
7.60E-01 (Median) | Methylation in Control | 9.66E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
HIV infection |
11 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC25A42 in HIV infection | [ 8 ] | |||
Location |
5'UTR (cg23956760) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.37E+00 | Statistic Test | p-value:4.51E-08; Z-score:2.25E+00 | ||
Methylation in Case |
6.51E-01 (Median) | Methylation in Control | 4.76E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC25A42 in HIV infection | [ 8 ] | |||
Location |
TSS1500 (cg22145172) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.35E+00 | Statistic Test | p-value:2.37E-05; Z-score:1.38E+00 | ||
Methylation in Case |
8.53E-02 (Median) | Methylation in Control | 6.31E-02 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC25A42 in HIV infection | [ 8 ] | |||
Location |
TSS1500 (cg07855993) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.12E+00 | Statistic Test | p-value:5.80E-03; Z-score:-8.27E-01 | ||
Methylation in Case |
7.08E-02 (Median) | Methylation in Control | 7.91E-02 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC25A42 in HIV infection | [ 8 ] | |||
Location |
TSS200 (cg23474268) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.09E+00 | Statistic Test | p-value:3.64E-03; Z-score:-6.38E-01 | ||
Methylation in Case |
9.04E-02 (Median) | Methylation in Control | 9.87E-02 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC25A42 in HIV infection | [ 8 ] | |||
Location |
TSS200 (cg18420266) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.08E+00 | Statistic Test | p-value:5.24E-03; Z-score:5.82E-01 | ||
Methylation in Case |
7.66E-02 (Median) | Methylation in Control | 7.07E-02 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC25A42 in HIV infection | [ 8 ] | |||
Location |
Body (cg04661001) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.06E+00 | Statistic Test | p-value:1.13E-02; Z-score:1.09E+00 | ||
Methylation in Case |
9.45E-01 (Median) | Methylation in Control | 8.90E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC25A42 in HIV infection | [ 8 ] | |||
Location |
Body (cg10665321) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.27E+00 | Statistic Test | p-value:2.95E-02; Z-score:8.72E-01 | ||
Methylation in Case |
3.42E-01 (Median) | Methylation in Control | 2.69E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC25A42 in HIV infection | [ 8 ] | |||
Location |
Body (cg02595575) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.64E+00 | Statistic Test | p-value:3.07E-02; Z-score:8.73E-01 | ||
Methylation in Case |
7.41E-02 (Median) | Methylation in Control | 4.51E-02 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC25A42 in HIV infection | [ 8 ] | |||
Location |
Body (cg25612391) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.05E+00 | Statistic Test | p-value:3.07E-02; Z-score:8.99E-01 | ||
Methylation in Case |
9.32E-01 (Median) | Methylation in Control | 8.83E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon10 |
Methylation of SLC25A42 in HIV infection | [ 8 ] | |||
Location |
Body (cg20141652) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.09E+00 | Statistic Test | p-value:4.38E-02; Z-score:6.23E-01 | ||
Methylation in Case |
3.53E-01 (Median) | Methylation in Control | 3.23E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon11 |
Methylation of SLC25A42 in HIV infection | [ 8 ] | |||
Location |
Body (cg04460816) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.07E+00 | Statistic Test | p-value:4.60E-02; Z-score:6.45E-01 | ||
Methylation in Case |
4.44E-01 (Median) | Methylation in Control | 4.14E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Pancretic ductal adenocarcinoma |
11 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC25A42 in pancretic ductal adenocarcinoma | [ 9 ] | |||
Location |
5'UTR (cg25788793) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.80E+00 | Statistic Test | p-value:2.60E-20; Z-score:-3.41E+00 | ||
Methylation in Case |
1.94E-01 (Median) | Methylation in Control | 3.49E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC25A42 in pancretic ductal adenocarcinoma | [ 9 ] | |||
Location |
TSS1500 (cg20536716) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.34E+00 | Statistic Test | p-value:3.46E-10; Z-score:1.12E+00 | ||
Methylation in Case |
4.96E-02 (Median) | Methylation in Control | 3.71E-02 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC25A42 in pancretic ductal adenocarcinoma | [ 9 ] | |||
Location |
TSS1500 (cg20092728) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.12E+00 | Statistic Test | p-value:7.84E-05; Z-score:1.48E+00 | ||
Methylation in Case |
7.78E-01 (Median) | Methylation in Control | 6.94E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC25A42 in pancretic ductal adenocarcinoma | [ 9 ] | |||
Location |
TSS200 (cg17580331) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.08E+00 | Statistic Test | p-value:7.79E-04; Z-score:4.38E-01 | ||
Methylation in Case |
3.90E-01 (Median) | Methylation in Control | 3.63E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC25A42 in pancretic ductal adenocarcinoma | [ 9 ] | |||
Location |
Body (cg21380183) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-3.87E+00 | Statistic Test | p-value:4.10E-14; Z-score:-2.83E+00 | ||
Methylation in Case |
1.33E-01 (Median) | Methylation in Control | 5.13E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC25A42 in pancretic ductal adenocarcinoma | [ 9 ] | |||
Location |
Body (cg18685243) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:2.16E+00 | Statistic Test | p-value:1.47E-13; Z-score:1.59E+00 | ||
Methylation in Case |
1.53E-01 (Median) | Methylation in Control | 7.07E-02 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC25A42 in pancretic ductal adenocarcinoma | [ 9 ] | |||
Location |
Body (cg19326876) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:2.35E+00 | Statistic Test | p-value:8.26E-08; Z-score:2.11E+00 | ||
Methylation in Case |
3.92E-01 (Median) | Methylation in Control | 1.66E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC25A42 in pancretic ductal adenocarcinoma | [ 9 ] | |||
Location |
Body (cg02042585) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.03E+00 | Statistic Test | p-value:5.70E-03; Z-score:3.57E-01 | ||
Methylation in Case |
8.21E-01 (Median) | Methylation in Control | 7.99E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC25A42 in pancretic ductal adenocarcinoma | [ 9 ] | |||
Location |
Body (cg06665333) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.02E+00 | Statistic Test | p-value:6.23E-03; Z-score:2.96E-01 | ||
Methylation in Case |
8.59E-01 (Median) | Methylation in Control | 8.40E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon10 |
Methylation of SLC25A42 in pancretic ductal adenocarcinoma | [ 9 ] | |||
Location |
Body (cg03281154) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.03E+00 | Statistic Test | p-value:4.92E-02; Z-score:-5.12E-01 | ||
Methylation in Case |
7.60E-01 (Median) | Methylation in Control | 7.83E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon11 |
Methylation of SLC25A42 in pancretic ductal adenocarcinoma | [ 9 ] | |||
Location |
3'UTR (cg26826434) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.02E+00 | Statistic Test | p-value:3.70E-03; Z-score:8.96E-01 | ||
Methylation in Case |
8.55E-01 (Median) | Methylation in Control | 8.38E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Panic disorder |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC25A42 in panic disorder | [ 10 ] | |||
Location |
5'UTR (cg23956760) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-8.10E-01 | Statistic Test | p-value:3.07E-02; Z-score:-2.38E-01 | ||
Methylation in Case |
-6.23E-01 (Median) | Methylation in Control | -5.05E-01 (Median) | ||
Studied Phenotype |
Panic disorder[ ICD-11:6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Papillary thyroid cancer |
6 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC25A42 in papillary thyroid cancer | [ 11 ] | |||
Location |
5'UTR (cg23956760) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.47E+00 | Statistic Test | p-value:5.98E-19; Z-score:2.95E+00 | ||
Methylation in Case |
6.44E-01 (Median) | Methylation in Control | 4.37E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC25A42 in papillary thyroid cancer | [ 11 ] | |||
Location |
5'UTR (cg00813603) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.07E+00 | Statistic Test | p-value:2.13E-02; Z-score:3.70E-01 | ||
Methylation in Case |
3.30E-02 (Median) | Methylation in Control | 3.10E-02 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC25A42 in papillary thyroid cancer | [ 11 ] | |||
Location |
TSS1500 (cg22145172) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.41E+00 | Statistic Test | p-value:2.35E-05; Z-score:-1.33E+00 | ||
Methylation in Case |
1.03E-01 (Median) | Methylation in Control | 1.46E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC25A42 in papillary thyroid cancer | [ 11 ] | |||
Location |
TSS200 (cg13423282) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.05E+00 | Statistic Test | p-value:8.15E-03; Z-score:-2.80E-01 | ||
Methylation in Case |
6.17E-02 (Median) | Methylation in Control | 6.50E-02 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC25A42 in papillary thyroid cancer | [ 11 ] | |||
Location |
Body (cg11287443) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.07E+00 | Statistic Test | p-value:1.12E-08; Z-score:-2.05E+00 | ||
Methylation in Case |
8.30E-01 (Median) | Methylation in Control | 8.85E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC25A42 in papillary thyroid cancer | [ 11 ] | |||
Location |
Body (cg10665321) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.03E+00 | Statistic Test | p-value:2.36E-02; Z-score:3.89E-01 | ||
Methylation in Case |
5.97E-01 (Median) | Methylation in Control | 5.78E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Systemic lupus erythematosus |
6 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC25A42 in systemic lupus erythematosus | [ 12 ] | |||
Location |
5'UTR (cg01318291) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.03E+00 | Statistic Test | p-value:9.22E-03; Z-score:-1.54E-01 | ||
Methylation in Case |
6.79E-02 (Median) | Methylation in Control | 6.98E-02 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus[ ICD-11:4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC25A42 in systemic lupus erythematosus | [ 12 ] | |||
Location |
TSS200 (cg23474268) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:7.19E-03; Z-score:-3.57E-02 | ||
Methylation in Case |
1.23E-01 (Median) | Methylation in Control | 1.24E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus[ ICD-11:4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC25A42 in systemic lupus erythematosus | [ 12 ] | |||
Location |
TSS200 (cg18420266) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.01E+00 | Statistic Test | p-value:1.48E-02; Z-score:7.92E-02 | ||
Methylation in Case |
8.16E-02 (Median) | Methylation in Control | 8.06E-02 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus[ ICD-11:4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC25A42 in systemic lupus erythematosus | [ 12 ] | |||
Location |
TSS200 (cg22516671) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:3.79E-02; Z-score:-8.82E-02 | ||
Methylation in Case |
5.59E-02 (Median) | Methylation in Control | 5.68E-02 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus[ ICD-11:4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC25A42 in systemic lupus erythematosus | [ 12 ] | |||
Location |
Body (cg10665321) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.06E+00 | Statistic Test | p-value:5.91E-03; Z-score:1.49E-01 | ||
Methylation in Case |
2.34E-01 (Median) | Methylation in Control | 2.20E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus[ ICD-11:4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC25A42 in systemic lupus erythematosus | [ 12 ] | |||
Location |
3'UTR (cg02677865) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.00E+00 | Statistic Test | p-value:3.11E-02; Z-score:-1.05E-01 | ||
Methylation in Case |
8.69E-01 (Median) | Methylation in Control | 8.72E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus[ ICD-11:4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Lung adenocarcinoma |
6 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC25A42 in lung adenocarcinoma | [ 13 ] | |||
Location |
TSS1500 (cg22145172) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.20E+00 | Statistic Test | p-value:2.48E-02; Z-score:1.19E+00 | ||
Methylation in Case |
8.08E-02 (Median) | Methylation in Control | 6.73E-02 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC25A42 in lung adenocarcinoma | [ 13 ] | |||
Location |
TSS200 (cg13423282) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.11E+00 | Statistic Test | p-value:2.66E-02; Z-score:-9.19E-01 | ||
Methylation in Case |
5.25E-02 (Median) | Methylation in Control | 5.86E-02 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC25A42 in lung adenocarcinoma | [ 13 ] | |||
Location |
Body (cg10665321) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.24E+00 | Statistic Test | p-value:1.04E-03; Z-score:1.69E+00 | ||
Methylation in Case |
5.13E-01 (Median) | Methylation in Control | 4.15E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC25A42 in lung adenocarcinoma | [ 13 ] | |||
Location |
Body (cg20141652) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.22E+00 | Statistic Test | p-value:2.37E-03; Z-score:2.23E+00 | ||
Methylation in Case |
4.99E-01 (Median) | Methylation in Control | 4.08E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC25A42 in lung adenocarcinoma | [ 13 ] | |||
Location |
Body (cg04460816) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.09E+00 | Statistic Test | p-value:4.38E-03; Z-score:1.31E+00 | ||
Methylation in Case |
5.68E-01 (Median) | Methylation in Control | 5.20E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC25A42 in lung adenocarcinoma | [ 13 ] | |||
Location |
Body (cg02595575) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:2.02E+00 | Statistic Test | p-value:1.34E-02; Z-score:3.83E+00 | ||
Methylation in Case |
2.11E-01 (Median) | Methylation in Control | 1.04E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Prostate cancer |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC25A42 in prostate cancer | [ 14 ] | |||
Location |
TSS1500 (cg18783781) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.05E+00 | Statistic Test | p-value:4.91E-02; Z-score:1.28E+00 | ||
Methylation in Case |
9.19E-01 (Median) | Methylation in Control | 8.76E-01 (Median) | ||
Studied Phenotype |
Prostate cancer[ ICD-11:2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC25A42 in prostate cancer | [ 14 ] | |||
Location |
Body (cg05972316) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.96E+00 | Statistic Test | p-value:2.07E-02; Z-score:6.07E+00 | ||
Methylation in Case |
3.55E-01 (Median) | Methylation in Control | 1.82E-01 (Median) | ||
Studied Phenotype |
Prostate cancer[ ICD-11:2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC25A42 in prostate cancer | [ 14 ] | |||
Location |
Body (cg12651599) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.03E+00 | Statistic Test | p-value:3.05E-02; Z-score:1.59E+00 | ||
Methylation in Case |
9.26E-01 (Median) | Methylation in Control | 8.98E-01 (Median) | ||
Studied Phenotype |
Prostate cancer[ ICD-11:2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Depression |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC25A42 in depression | [ 15 ] | |||
Location |
TSS200 (cg08332492) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.06E+00 | Statistic Test | p-value:7.66E-03; Z-score:3.83E-01 | ||
Methylation in Case |
3.15E-02 (Median) | Methylation in Control | 2.96E-02 (Median) | ||
Studied Phenotype |
Depression[ ICD-11:6A8Z] | ||||
Experimental Material |
Patient tissue samples | ||||
microRNA |
|||||
Unclear Phenotype |
10 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
miR-1224 directly targets SLC25A42 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-1224 | miRNA Mature ID | miR-1224-3p | ||
miRNA Sequence |
CCCCACCUCCUCUCUCCUCAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon2 |
miR-1260a directly targets SLC25A42 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-1260a | miRNA Mature ID | miR-1260a | ||
miRNA Sequence |
AUCCCACCUCUGCCACCA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon3 |
miR-1260b directly targets SLC25A42 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-1260b | miRNA Mature ID | miR-1260b | ||
miRNA Sequence |
AUCCCACCACUGCCACCAU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon4 |
miR-2681 directly targets SLC25A42 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-2681 | miRNA Mature ID | miR-2681-3p | ||
miRNA Sequence |
UAUCAUGGAGUUGGUAAAGCAC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon5 |
miR-4433b directly targets SLC25A42 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4433b | miRNA Mature ID | miR-4433b-5p | ||
miRNA Sequence |
AUGUCCCACCCCCACUCCUGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon6 |
miR-532 directly targets SLC25A42 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-532 | miRNA Mature ID | miR-532-3p | ||
miRNA Sequence |
CCUCCCACACCCAAGGCUUGCA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon7 |
miR-551b directly targets SLC25A42 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-551b | miRNA Mature ID | miR-551b-5p | ||
miRNA Sequence |
GAAAUCAAGCGUGGGUGAGACC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon8 |
miR-5684 directly targets SLC25A42 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-5684 | miRNA Mature ID | miR-5684 | ||
miRNA Sequence |
AACUCUAGCCUGAGCAACAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon9 |
miR-6750 directly targets SLC25A42 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6750 | miRNA Mature ID | miR-6750-3p | ||
miRNA Sequence |
GAACUCACCCUCUGCUCCCAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon10 |
miR-96 directly targets SLC25A42 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-96 | miRNA Mature ID | miR-96-3p | ||
miRNA Sequence |
AAUCAUGUGCAGUGCCAAUAUG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.